T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan Chase
JPM
|
+$1.6B |
| 2 |
Verizon
VZ
|
+$1.3B |
| 3 |
US Bancorp
USB
|
+$1.26B |
| 4 |
Berkshire Hathaway Class B
BRK.B
|
+$1.26B |
| 5 |
Lam Research
LRCX
|
+$1.18B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$6.33B |
| 2 |
Tesla
TSLA
|
+$5.64B |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$4.91B |
| 4 |
TMX
Terminix Global Holdings, Inc.
TMX
|
+$3.44B |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.4B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.7% |
| 2 | Healthcare | 19.64% |
| 3 | Financials | 12.71% |
| 4 | Consumer Discretionary | 10.95% |
| 5 | Communication Services | 7.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
676
UiPath
PATH
$8.64B
| $47.1M | 0.01% |
3,703,850
+705,028
| +24% | +$8.71M |
|
|
DAWN
677
DELISTED
Day One Biopharmaceuticals
DAWN
| $47M | 0.01% |
2,182,578
+87,665
| +4% | +$1.8M |
|
678
AGCO
AGCO
$6.96B
| $46.8M | 0.01% |
337,081
-44,327
| -12% | -$5.47M |
|
679
State Street SPDR S&P Oil & Gas Exploration & Production ETF
XOP
$3.69B
| $46.7M | 0.01% |
343,490
| – | – |
|
680
Dow Inc
DOW
$21.9B
| $46.6M | 0.01% |
925,433
-20,787
| -2% | -$1.02M |
|
681
Kadant
KAI
$3.91B
| $46.6M | 0.01% |
262,452
+1,906
| +0.7% | +$339K |
|
682
M&T Bank
MTB
$36.6B
| $46.6M | 0.01% |
321,269
+87,985
| +38% | +$14.5M |
|
683
Selective Insurance
SIGI
$5.59B
| $46.5M | 0.01% |
525,083
+399,386
| +318% | +$36.4M |
|
684
Capri Holdings
CPRI
$1.77B
| $46.5M | 0.01% |
810,676
+60,322
| +8% | +$3.05M |
|
685
Westamerica Bancorp
WABC
$1.39B
| $46.3M | 0.01% |
785,265
-1,323,417
| -63% | -$77.8M |
|
686
Guardant Health
GH
$21.4B
| $46.3M | 0.01% |
1,702,980
+108,381
| +7% | +$4.96M |
|
687
Box
BOX
$4.66B
| $46M | 0.01% |
1,476,570
+6,987
| +0.5% | +$199K |
|
688
CRISPR Therapeutics
CRSP
$5.22B
| $45.6M | 0.01% |
1,122,848
-64,614
| -5% | -$3.43M |
|
689
Zai Lab
ZLAB
$2.92B
| $45.6M | 0.01% |
1,486,265
-121,416
| -8% | -$3.83M |
|
690
Louisiana-Pacific
LPX
$5.18B
| $45.6M | 0.01% |
770,360
-25,878
| -3% | -$1.53M |
|
691
Qualys
QLYS
$6.78B
| $45.2M | 0.01% |
402,671
+3,457
| +0.9% | +$432K |
|
692
SEACOR Marine Holdings
SMHI
$262M
| $45.2M | 0.01% |
4,929,460
-8,514
| -0.2% | -$66K |
|
693
APA Corp
APA
$14B
| $44.9M | 0.01% |
962,843
+136,513
| +17% | +$6.11M |
|
694
Darden Restaurants
DRI
$25.4B
| $44.6M | 0.01% |
322,171
+82,395
| +34% | +$11.5M |
|
695
VICI Properties
VICI
$29B
| $44.5M | 0.01% |
1,374,740
+8,760
| +0.6% | +$281K |
|
696
Prime Medicine
PRME
$575M
| $44.2M | 0.01% |
+2,378,582
| New | +$43M |
|
|
XM
697
DELISTED
Qualtrics International Inc. Class A Common Stock
XM
| $43.9M | 0.01% |
4,227,970
+210,713
| +5% | +$2.21M |
|
698
Zentalis Pharmaceuticals
ZNTL
$297M
| $43.8M | 0.01% |
2,176,700
-41,040
| -2% | -$883K |
|
699
Consolidated Edison
ED
$40.1B
| $43.6M | 0.01% |
457,560
+920
| +0.2% | +$83.7K |
|
|
ANSS
700
DELISTED
Ansys
ANSS
| $43.1M | 0.01% |
178,227
-320
| -0.2% | -$74.5K |
|
Similar funds
T. Rowe Price Associates's Q4 2022 Portfolio in Review
As of Q4 2022, T. Rowe Price Associates held 3,066 positions worth $622B, up 1.8% from $610B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
T. Rowe Price Associates's Q4 2022 filing shows 113 new, 1,569 increased, 1,081 reduced and 107 closed positions. Its largest new stake was GE HealthCare: 6,360,001 shares worth $371M. The largest sale was Amazon, an estimated $6.33B.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 26% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q4 2022 buy was GE HealthCare: 6,360,001 shares worth $371M.
- T. Rowe Price Associates added most to JPMorgan Chase in Q4 2022, an estimated $1.6B increase.
- T. Rowe Price Associates's biggest Q4 2022 reduction was Amazon, cutting an estimated $6.33B.
- T. Rowe Price Associates fully exited Terminix Global Holdings, Inc. in Q4 2022, selling an estimated $3.44B.
- T. Rowe Price Associates's ten largest holdings make up 27% of its $622B portfolio in Q4 2022.
- T. Rowe Price Associates opened 113 new positions and closed 107 in Q4 2022.
- T. Rowe Price Associates's portfolio value rose 1.8% quarter-over-quarter to $622B.
Based on T. Rowe Price Associates's 13F filing for Q4 2022, filed 14 Feb 2023.